Sotabase

Career

· Senior Scientific Director, Healthcare Consultancy Group - HCG2025–
· Scientific Director, Healthcare Consultancy Group - HCG2024–2025
· Scientific Director, ProEd Communications2023–2024
· Associate Scientific Director, ProEd Communications2022–2023
· Assistant Scientific Director, ProEd Communications2021–2022
· Clinical Research Manager, Department Of Obstetrics And Gynaecology, Mount Sinai Hospital (Toronto), Sinai Health System2019–2021
· Scientific Medical Writer, Mount Sinai Hospital (Toronto), Sinai Health System2017–2019
· Freelance Medical Writer, SCRIPT Medical2016–2017
· Manager, Zebrafish Core Facility, The Hospital for Sick Children2014–2017
· Research Associate, Hospital for Sick Children2010–2014
· Postdoctoral Fellow, Huntsman Cancer Institute2006–2010

Publications (25)

Antioxidants and Redox Signaling · 2006
46
cited
Recognition of nonpeptide antigens by human V gamma 9V delta 2 T cells requires contact with cells of human origin.
Clinical and Experimental Immunology · 2004
32
cited
Journal of Biological Chemistry · 2002
20
cited
Novel CD8+ T cell antagonists based on beta 2-microglobulin.
Journal of Biological Chemistry · 2002
2
cited
and CD8 on the Cell Surface Absence of an Interaction between pMHCI on CTL Activation and Occurs in the Binding: This Is Paralleled by Their Effects Peptide-MHC Class I (pMHCI) Multimer Anti-CD8 Antibodies Can Inhibit or Enhance
2013
CD8 on the Cell Surface and of an Interaction between pMHCI Activation and Occurs in the Absence Paralleled by Their Effects on CTL (pMHCI) Multimer Binding: This Is Enhance Peptide-MHC Class I Anti-CD8 Antibodies Can Inhibit or
2010
Cell Surface Absence of an Interaction between pMHCI on CTL Activation and Occurs in the Binding : This Is Paralleled by Their Effects Peptide-MHC Class I ( pMHCI ) Multimer Anti-CD 8 Antibodies Can Inhibit or Enhance
2003
Sotabase
Sarah Hutchinson | Researcher Profile | Sotabase | Sotabase